WecLac® Clinical Strains
Clinically Studied
SCI/Patent Supported
SCI/Patent Supported
Akkermansia muciniphila Akk11
Potency
600B AFU/g
Source of Strain
Healthy infant intestines
Deposit Number
ATCC PTA-127863 DSM 35205
Functions
-
Digestive Health -
Metabolic Health -
Bone Health -
Weight Management -
Immune Health
Akkermansia muciniphila Capsules Sample
Specialization Advantages
40,000+ Strain Resources
GRAS certified
Allergen free
SCI / Patent supported
High survivability
Non-GMO verified
Clinically studied
High colonisation
Precise function
Industrialization Advantages
High potency
Low water activity
Cost-effectiveness
High stability
Fast delivery
cGMP standard
Excellent batch stability
Stable supply chain
Advanced equipment
Application
-
Dietary Supplement -
Dairy -
Food -
Precision Medicine -
Personal Care -
Feed Additive/Pet
WecLac® Clinical Strains
Bifidobacterium animalis subsp. lactis BLa80
Lacticaseibacillus paracasei LC86
Lactobacillus acidophilus LA85
Lactiplantibacillus plantarum Lp05
Weizmannia coagulans BC99
Bifidobacterium longum subsp. longum BL21
Pediococcus acidilactici PA53
Bifidobacterium breve BBr60
Lacticaseibacillus rhamnosus LRa05
No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Leave a Message
Email
Linkedin